Cano Health, Inc. Balance Sheet

Ask AI

Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Financial Statements

Income Statement Balance Sheet Cashflow Statement

Consolidated balance sheets

In millions of USD, except per-share amounts

	Q1 FY2024 As of Mar 31, 2024	Q4 FY2023 As of Dec 31, 2023	Q3 FY2023 As of Sep 30, 2023	Q2 FY2023 As of Jun 30, 2023	Q1 FY2023 As of Mar 31, 2023	Q4 FY2022 As of Dec 31, 2022	Q3 FY2022 As of Sep 30, 2022	Q2 FY2022 As of Jun 30, 2022	Q1 FY2022 As of Mar 31, 2022	Q4 FY2021 As of Dec 31, 2021	Q3 FY2021 As of Sep 30, 2021	Q2 FY2021 As of Jun 30, 2021	Q1 FY2021 As of Mar 31, 2021	Q4 FY2020 As of Dec 31, 2020	Q3 FY2020 As of Sep 30, 2020	Q2 FY2020 As of Jun 30, 2020
Assets
Current assets:
Cash
Prepaid expenses
Cash, cash equivalents and restricted cash
Accounts receivable, net of unpaid service provider costs
Inventory
Equity securities at fair value
Prepaid expenses and other current assets
Total current assets

Cash and marketable securities held in Trust Account
Property and equipment, net
Operating lease right-of-use assets
Goodwill
Payor relationships, net
Other intangibles, net
Other assets
Total assets

Liabilities and stockholders' deficit
Current liabilities:
Accrued expenses
Accrued offering costs
Accounts payable and accrued expenses (Related parties comprised $6,973 and $6,239 as of March 31, 2024 and December 31, 2023, respectively)
Deferred revenue (Related parties comprised $0 and $988 as of December 31, 2021 and December 31, 2020, respectively)
Current portion of notes payable, net of debt issuance costs
Current portion of equipment loans
Current portion of capital lease obligations
Current portion of finance lease liabilities
Current portion of contingent consideration
Current portions due to sellers
Current portion of operating lease liabilities
Other current liabilities
Total current liabilities

Deferred underwriting fee payable
Notes payable, net of debt issuance costs
Long term portion of operating lease liabilities
Warrant liabilities
Equipment loans, net of current portion
Capital lease obligations, net of current portion
Deferred rent (Related parties comprised $0 and $92 as of September 30, 2021 and December 31, 2020, respectively)
Long term portion of finance lease liabilities
Deferred revenue, net of current portion (Related parties comprised of $0 and $4,277 as of December 31, 2021 and December 31, 2020, respectively)
Due to sellers, net of current portion
Long-term portion of contingent consideration
Other liabilities
Liabilities subject to compromise
Total liabilities
Class A ordinary shares subject to possible redemption, 55,152,673 and 56,966,114 shares at $10.00 per share as of March 31, 2021 and December 31, 2020, respectively
Class A common stock
Total class A ordinary shares subject to possible redemption, 55,152,673 and 56,966,114 shares at $10.00 per share as of March 31, 2021 and December 31, 2020, respectively

Preference shares, $0.0001 par value; 1,000,000 shares authorized; none issued and outstanding
Stockholders’ Deficit
Common stock
Class A common stock
Class B common stock
Members' capital
Additional paid-in capital
Accumulated deficit
Notes receivable, related parties
Total Stockholders' Deficit before non-controlling interests
Non-controlling interests
Total Stockholders' Deficit
Total Liabilities and Stockholders' Deficit
Other

Comments